Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysis

Psychiatry Res. 2023 Oct:328:115452. doi: 10.1016/j.psychres.2023.115452. Epub 2023 Aug 28.

Abstract

Our meta-analysis demonstrated that intermittent theta burst stimulation (iTBS)/bilateral-TBS (Bi-TBS) and high-frequency repetitive transcranial magnetic stimulation (HF-rTMS)/bilateral-rTMS (Bi-rTMS) had similar efficacy, acceptability, and safety profiles for antidepressant treatment-resistant major depressive disorder (AD-TRD). In our sensitivity analysis that excluded a study that compared Bi-TBS with Bi-rTMS for older adults, all efficacy outcomes were also comparable between iTBS and HF-rTMS. Because iTBS does not require higher stimulation intensity and a longer stimulus time than conventional HF-rTMS protocols, we speculated that for those with AD-TRD, iTBS/Bi-TBS is a more helpful therapeutic modality in clinical practice than HF-rTMS/Bi-rTMS.

Keywords: High-frequency repetitive transcranial magnetic stimulation; Intermittent theta burst stimulation; Systematic review and meta-analysis.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antidepressive Agents
  • Depressive Disorder, Major* / therapy
  • Depressive Disorder, Treatment-Resistant* / therapy
  • Humans
  • Transcranial Magnetic Stimulation / methods
  • Treatment Outcome

Substances

  • Antidepressive Agents